NCT01504295View on ClinicalTrials.gov

A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

February 28, 2015

Conditions

Alcoholism,Alcoholic Liver Disease

Interventions

DRUG

Metadoxine

Improve Liver Function and Reduce ALcohol Use

Trial Locations (1)

02912

Brown University Center for Alcohol and Addiction Studies, Providence

Sponsors

Lead Sponsor

Brown University

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Brown University

OTHER